| Predictive and prognostic molecular markers for cancer medicine S Mehta, A Shelling, A Muthukaruppan, A Lasham, C Blenkiron, G Laking, ... Therapeutic advances in medical oncology 2 (2), 125-148, 2010 | 250 | 2010 |
| YB-1: oncoprotein, prognostic marker and therapeutic target? A Lasham, CG Print, AG Woolley, SE Dunn, AW Braithwaite Biochemical Journal 449 (1), 11-23, 2013 | 231 | 2013 |
| γ‐Aminobutyric AcidA Receptor Heterogeneity Is Increased by Alternative Splicing of a Novel β‐Subunit Gene Transcript AN Bateson, A Lasham, MG Darlison Journal of neurochemistry 56 (4), 1437-1440, 1991 | 198 | 1991 |
| Regulation of the human fas promoter by YB-1, Purα and AP-1 transcription factors A Lasham, E Lindridge, F Rudert, R Onrust, J Watson Gene 252 (1-2), 1-13, 2000 | 187 | 2000 |
| The Y-box-binding protein, YB1, is a potential negative regulator of the p53 tumor suppressor A Lasham, S Moloney, T Hale, C Homer, YF Zhang, JG Murison, ... Journal of Biological Chemistry 278 (37), 35516-35523, 2003 | 179 | 2003 |
| YB-1, the E2F pathway, and regulation of tumor cell growth A Lasham, W Samuel, H Cao, R Patel, R Mehta, JL Stern, G Reid, ... Journal of the National Cancer Institute 104 (2), 133-146, 2012 | 134 | 2012 |
| Y-box factor YB1 controls p53 apoptotic function C Homer, DA Knight, L Hananeia, P Sheard, J Risk, A Lasham, JA Royds, ... Oncogene 24 (56), 8314-8325, 2005 | 131 | 2005 |
| Development of biodegradable PLGA nanoparticles surface engineered with hyaluronic acid for targeted delivery of paclitaxel to triple negative breast cancer cells BBS Cerqueira, A Lasham, AN Shelling, R Al-Kassas Materials Science and Engineering: C 76, 593-600, 2017 | 100 | 2017 |
| Nanoparticle therapeutics: Technologies and methods for overcoming cancer BBS Cerqueira, A Lasham, AN Shelling, R Al-Kassas European Journal of Pharmaceutics and Biopharmaceutics 97, 140-151, 2015 | 95 | 2015 |
| Nuclear localization of Y-box factor YB1 requires wild-type p53 YF Zhang, C Homer, SJ Edwards, L Hananeia, A Lasham, J Royds, ... Oncogene 22 (18), 2782-2794, 2003 | 93 | 2003 |
| Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers AL Stratford, K Reipas, K Hu, A Fotovati, R Brough, J Frankum, M Takhar, ... Stem cells 30 (7), 1338-1348, 2012 | 83 | 2012 |
| Conserved Organization of γ‐Aminobutyric AcidAReceptor Genes: Cloning and Analysis of the Chicken β4‐Subunit Gene A Lasham, E Vreugdenhil, AN Bateson, EA Barnard, MG Darlison Journal of neurochemistry 57 (1), 352-355, 1991 | 65 | 1991 |
| N-methyl-D-aspartate receptors amplify activation and aggregation of human platelets ML Kalev-Zylinska, TN Green, MC Morel-Kopp, PP Sun, YE Park, ... Thrombosis research 133 (5), 837-847, 2014 | 52 | 2014 |
| Links between the oncoprotein YB-1 and small non-coding RNAs in breast cancer C Blenkiron, DG Hurley, S Fitzgerald, CG Print, A Lasham PloS one 8 (11), e80171, 2013 | 52 | 2013 |
| Prognostic association of YB-1 expression in breast cancers: a matter of antibody AG Woolley, M Algie, W Samuel, R Harfoot, A Wiles, NA Hung, PH Tan, ... PloS one 6 (6), e20603, 2011 | 51 | 2011 |
| Dysregulated expression of the MicroRNA miR-137 and its target YBX1 contribute to the invasive characteristics of malignant pleural mesothelioma TG Johnson, K Schelch, YY Cheng, M Williams, KH Sarun, MB Kirschner, ... Journal of Thoracic Oncology 13 (2), 258-272, 2018 | 43 | 2018 |
| A rapid and sensitive method to detect siRNA-mediated mRNA cleavage in vivo using 5′ RACE and a molecular beacon probe A Lasham, M Herbert, N Coppieters ‘t Wallant, R Patel, S Feng, M Eszes, ... Nucleic acids research 38 (3), e19-e19, 2010 | 39 | 2010 |
| A Study of TP53 RNA Splicing Illustrates Pitfalls of RNA-seq Methodology S Mehta, P Tsai, A Lasham, H Campbell, R Reddel, A Braithwaite, C Print Cancer Research 76 (24), 7151-7159, 2016 | 37 | 2016 |
| A novel EGR‐1 dependent mechanism for YB‐1 modulation of paclitaxel response in a triple negative breast cancer cell line A Lasham, SY Mehta, SJ Fitzgerald, AG Woolley, JI Hearn, DG Hurley, ... International journal of cancer 139 (5), 1157-1170, 2016 | 37 | 2016 |
| Nanoparticulate carriers: An emerging tool for breast cancer therapy P Tharkar, AU Madani, A Lasham, AN Shelling, R Al-Kassas Journal of drug targeting 23 (2), 97-108, 2015 | 27 | 2015 |
